BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2895116)

  • 1. High-performance liquid chromatographic determination of a new H2 blocker (ORF 17 910) in plasma.
    Huang SM; Tran-Phan H
    J Chromatogr; 1987 Dec; 423():358-64. PubMed ID: 2895116
    [No Abstract]   [Full Text] [Related]  

  • 2. Highly sensitive determination of 2-hydroxy-N-(3-[m-(1-piperidinylmethyl) phenoxy]propyl)acetamide (desacetyl TZU-0460) in rat plasma by high-performance liquid chromatography.
    Iwamura S; Tsukamoto K
    J Chromatogr; 1987 Jan; 413():370-5. PubMed ID: 2881939
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of a new H2 receptor antagonist, 3-amino-5-[3-[4-(1-piperidinoindanyloxy)]propylamino]-1-methyl-1 H-1,2,4-triazole, in human plasma and urine by high-performance liquid chromatography.
    Miksic JR; Rivel ER; Rush K
    J Chromatogr; 1988 Jun; 428(1):113-21. PubMed ID: 2902101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-performance liquid chromatographic determination of oxmetidine in human plasma: comparison of liquid-liquid and liquid-solid extraction techniques.
    McDowall RD; Murkitt GS; Walford JA
    J Chromatogr; 1984 Dec; 317():475-81. PubMed ID: 6152271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical method for the quantification of famotidine, an H2-receptor blocker, in plasma and urine.
    Vincek WC; Constanzer ML; Hessey GA; Bayne WF
    J Chromatogr; 1985 Mar; 338(2):438-43. PubMed ID: 2860117
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma analysis and pharmacokinetics of zaltidine, an H2-antagonist, in cattle after intravenous, intramuscular, subcutaneous, and oral administration.
    Hunter RP; Canning PC; Hassfurther R
    J Vet Pharmacol Ther; 1996 Aug; 19(4):326-8. PubMed ID: 8866466
    [No Abstract]   [Full Text] [Related]  

  • 7. [Determination of new H2-receptor antagonist Z-300 in plasma by high-performance liquid chromatography with fluorescence detection].
    Hoshino M; Watanabe Y; Hamasaki Y; Masubuchi M; Okahira A
    Yakugaku Zasshi; 1993 Aug; 113(8):586-90. PubMed ID: 8104246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of nizatidine and two of its main metabolites in human serum using high-performance liquid chromatography.
    Tracqui A; Kintz P; Mangin P
    J Chromatogr; 1990 Aug; 529(2):369-76. PubMed ID: 1977754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of piquindone in canine plasma and urine by high-performance liquid chromatography.
    Brooks MA; Lee TL
    J Chromatogr; 1986 Mar; 375(2):349-57. PubMed ID: 2871038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous determination of amoxicillin and ranitidine in rat plasma by high-performance liquid chromatography.
    Li W; Tan F; Zhao K
    J Pharm Biomed Anal; 2006 May; 41(2):594-8. PubMed ID: 16364584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of famotidine in man.
    Kroemer H; Klotz U
    Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):458-63. PubMed ID: 2888738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid chromatography of a new 2-amino-2-oxazoline: application to pharmacokinetic studies in dogs.
    Damaj MI; Trouvin JH; Lambrey B; Jacquot C
    J Pharm Sci; 1990 Jun; 79(6):516-8. PubMed ID: 2395095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive determination of ranitidine in rabbit plasma by HPLC with fluorescence detection.
    Khedr A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Feb; 862(1-2):175-80. PubMed ID: 18166505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validated HPLC method for the determination of ranitidine in human serum and its application in a clinical pharmacokinetic study.
    Kumar MK; Jayasagar G; Chandrasekhar K; Ashok T; Rao YM
    Pharmazie; 2003 Apr; 58(4):284-5. PubMed ID: 12749414
    [No Abstract]   [Full Text] [Related]  

  • 15. High-performance liquid chromatographic determination of famotidine in urine.
    Rahman A; Hoffman NE
    J Chromatogr; 1988 Jul; 428(2):395-401. PubMed ID: 2905703
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of ciprofloxacin in human serum by liquid chromatography.
    Pou-Clave L; Campos-Barreda F; Pascual-Mostaza C
    J Chromatogr; 1991 Jan; 563(1):211-5. PubMed ID: 2061391
    [No Abstract]   [Full Text] [Related]  

  • 17. HPLC fluorescence method for the determination of nizatidine in human plasma and its application to pharmacokinetic study.
    Çakar MB; Ulu ST
    Luminescence; 2014 Jun; 29(4):357-61. PubMed ID: 23836529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatographic assay with ultraviolet detection for the determination of etoperidone and two active metabolites, 5-(1-hydroxyethyl) etoperidone and 1-(3-chlorophenyl)piperazine, in plasma.
    Holland ML; Heebner ET
    J Chromatogr; 1991 Jul; 567(2):433-40. PubMed ID: 1939475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative high-performance liquid chromatography determination of ICI 125,211 in plasma.
    Monson K; Simon RK; Malbica JO
    J Anal Toxicol; 1980; 4(5):244-9. PubMed ID: 6108390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-performance liquid chromatographic assay of dilevalol, a beta-adrenoceptor blocker, in rat and human plasma.
    Dionisotti S; Bamonte F; Monopoli A
    J Chromatogr; 1990 Sep; 530(2):458-62. PubMed ID: 1981890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.